Therapeutic Electrophysical Agents: Evidence Behind Practice

Therapeutic Electrophysical Agents: Evidence Behind Practice, THIRD EDITION
	COPYRIGHT
	DEDICATION
	QUOTES
	ABOUT THE AUTHOR
	ACKNOWLEDGMENTS
	REVIEWERS
	PREFACE
		ENHANCED AND NEW CONTENT PRESENTATION
		NEW AND UNIQUE ANCILLARY MATERIAL
	CONTENTS
	Additional Resources
	PART I: Foundations
		Chapter 1: Therapeutic Electrophysical Agents in Health Care
			Chapter Outline
			Learning Objectives
			I. THE USE OF ELECTROPHYSICAL AGENTS
			II. INTERNATIONAL SOCIETY FOR ELECTROPHYSICAL AGENTS IN PHYSICAL THERAPY
			III. THE DISABLEMENT CONCEPT
			IV. TODAY’S DELIVERY OF ELECTROPHYSICAL AGENTS
			V. EMERGING THERAPIES
			VI. LIMITED THERAPEUTIC SCOPE
			VII. THE BOTTOM LINE
			VIII. CRITICAL THINKING QUESTIONS
			IX. REFERENCES
		Chapter 2: Toward a Practice Based on Evidence
			Chapter Outline
			Learning Objectives
			I. TODAY’S CLINICAL DECISION MAKING
			II. THE CONCEPT OF EVIDENCE
			III. EVIDENCE-BASED PRACTICE: WHAT IS IT?
			IV. BARRIERS TO EVIDENCE-BASED CLINICAL DECISION MAKING
			V. EVIDENCE-BASED CLINICAL DECISION MAKING PROTOCOL
			VI. BENEFIT OF EVIDENCE-BASED CLINICAL DECISION MAKING
			VII. CHALENGE AND LIMITATION
			VIII. THE BOTTOM LINE
			IX. CRITICAL THINKING QUESTIONS
			X. REFERENCES
		Chapter 3: Soft-Tissue Healing Process
			Chapter Outline
			Learning Objectives
			I. FOUNDATION
			II. THE HEALING PROCESS
			III. SKIN
			IV. TENDON AND LIGAMENT
			V. ARTICULAR CARTILAGE
			VI. BONE
			VII. SKELETAL MUSCLE
			VIII. PERIPHERAL NERVE
			IX. VASCULATURE
			X. LYMPHATIC SYSTEM
			XI. THE BOTTOM LINE
			XII. CRITICAL THINKING QUESTIONS
			XIII. REFERENCES
		Chapter 4: Pain Following Soft-Tissue Pathology
			Chapter Outline
			Learning Objectives
			I. CONCEPT, DEFINITION, AND PUZZLE
			II. THRESHOLD VERSUS TOLERANCE
			III. ACUTE VERSUS CHRONIC
			IV. PAIN CATEGORIES
			V. PAIN DIMENSIONS
			VI. THE EXPERIENCE OF SOMATIC PAIN
			VII. SOMATIC PAIN MODULATION
			VIII. PAIN ASSESSMENT TOOLS AND SCORING
			IX. ASSESSMENT OF PATIENTS WITH LIMITED ABILITY TO COMMUNICATE
			X. SPECTRUM OF PAIN MANAGEMENT
			XI. THE BOTTOM LINE
			XII. CRITICAL THINKING QUESTIONS
			XIII. REFERENCES
		Chapter 5: Purchase, Electrical Safety, and Maintenance
			Chapter Outline
			Learning Objectives
			I. THE PURCHASING PROCESS
			II. EIGHT-STEP APPROACH TO PURCHASING ELECTROPHYSICAL AGENTS
			III. ELECTRICAL HAZARDS
			IV. GENESIS OF AN ELECTRICAL SHOCK
			V. PROTECTION AGAINST ELECTRICAL SHOCKS
			VI. PREVENTION, OPERATIONAL SAFETY, AND MAINTENANCE
			VII. IMMEDIATE PROCEDURES FOLOWING A SEVERE MACROSHOCK
			VIII. THE BOTTOM LINE
			IX. CRITICAL THINKING QUESTIONS
			X. REFERENCES
		Chapter 6: Therapeutic Spectrum, Selection, and Indication
			Chapter Outline
			Learning Objectives
			I. THERAPEUTIC SPECTRUM
			II. JUDICIOUS SELECTION AND TIMELY APPLICATION
			III. FRAMEWORK FOR SELECTION
			IV. PRESENT AND FUTURE MANAGEMENT OF SOFT-TISSUE PATHOLOGY
			V. THE BOTTOM LINE
			VI. CRITICAL THINKING QUESTIONS
			VII. REFERENCES
	PART II: Thermal Agents
		Chapter 7: Thermotherapy
			I. FOUNDATION
			II. BIOPHYSICAL CHARACTERISTICS
			III. THERAPEUTIC EFFECTS AND INDICATIONS
			IV. DOSIMETRY
			V. APPLICATION, CONTRAINDICATIONS, AND RISKS
			VI. THE BOTTOM LINE
			VII. CRITICAL THINKING QUESTIONS
			VIII. REFERENCES
		Chapter 8: Cryotherapy
			Chapter Outline
			Learning Objectives
			I. FOUNDATION
			II. BIOPHYSICAL CHARACTERISTICS
			III. THERAPEUTIC EFFECTS AND INDICATIONS
			IV. DOSIMETRY
			V. APPLICATION, CONTRAINDICATIONS, AND RISKS
			VI. THE BOTTOM LINE
			VII. CRITICAL THINKING QUESTIONS
			VIII. REFERENCES
		Chapter 9: Hydrotherapy
			Chapter Outline
			Learning Objectives
			I. FOUNDATION
			II. BIOPHYSICAL CHARACTERISTICS
			III. THERAPEUTIC EFFECTS AND INDICATIONS
			IV. DOSIMETRY
			V. APPLICATION, CONTRAINDICATIONS, AND RISKS
			VI. THE BOTTOM LINE
			VII. CRITICAL THINKING QUESTIONS
			VIII. REFERENCES
	PART III: Electromagnetic Agents
		Chapter 10: Shortwave Diathermy
			Chapter Outline
			Learning Objectives
			I. FOUNDATION
			II. BIOPHYSICAL CHARACTERISTICS
			III. THERAPEUTIC EFFECTS AND INDICATIONS
			IV. DOSIMETRY
			V. APPLICATION, CONTRAINDICATIONS, AND RISKS
			VI. THE BOTTOM LINE
			VII. CRITICAL THINKING QUESTIONS
			VIII. REFERENCES
		Chapter 11: Low-Level Laser Therapy
			Chapter Outline
			Learning Objectives
			I. FOUNDATION
			II. BIOPHYSICAL CHARACTERISTICS
			III. THERAPEUTIC EFFECTS AND INDICATIONS
			IV. DOSIMETRY
			V. APPLICATION, CONTRAINDICATIONS, AND RISKS
			VI. THE BOTTOM LINE
			VII. CRITICAL THINKING QUESTIONS
			VIII. REFERENCES
		Chapter 12: Ultraviolet
			Chapter Outline
			Learning Objectives
			I. FOUNDATION
			II. BIOPHYSICAL CHARACTERISTICS
			III. THERAPEUTIC EFFECTS AND INDICATIONS
			IV. DOSIMETRY
			V. APPLICATION, CONTRAINDICATIONS, AND RISKS
			VI. THE BOTTOM LINE
			VII. CRITICAL THINKING QUESTIONS
			VIII. REFERENCES
	PART IV: Electrical Agents
		Chapter 13: Neuromuscular Electrical Stimulation
			Chapter Outline
			Learning Objectives
			I. FOUNDATION
			II. BIOPHYSICAL CHARACTERISTICS
			III. THERAPEUTIC EFFECTS AND INDICATIONS
			IV. DOSIMETRY
			V. APPLICATION, CONTRAINDICATIONS, AND RISKS
			VI. THE BOTTOM LINE
			VII. CRITICAL THINKING QUESTIONS
			VIII. REFERENCES
		Chapter 14: Transcutaneous Electrical Nerve Stimulation
			Chapter Outline
			Learning Objectives
			I. FOUNDATION
			II. BIOPHYSICAL CHARACTERISTICS
			III. THERAPEUTIC EFFECTS AND INDICATIONS
			IV. DOSIMETRY
			V. APPLICATION, CONTRAINDICATIONS, AND RISKS
			VI. THE BOTTOM LINE
			VII. CRITICAL THINKING QUESTIONS
			VIII. REFERENCES
		Chapter 15: Electrical Stimulation for Tissue Healing and Repair
			Chapter Outline
			Learning Objectives
			I. FOUNDATION
			II. BIOPHYSICAL CHARACTERISTICS
			III. THERAPEUTIC EFFECTS AND INDICATIONS
			IV. DOSIMETRY
			V. APPLICATION, CONTRAINDICATIONS, AND RISKS
			VI. THE BOTTOM LINE
			VII. CRITICAL THINKING QUESTIONS
			VIII. REFERENCES
		Chapter 16: Iontophoresis
			Chapter Outline
			Learning Objectives
			I. FOUNDATION
			II. BIOPHYSICAL CHARACTERISTICS
			III. THERAPEUTIC EFFECTS AND INDICATIONS
			IV. DOSIMETRY
			V. APPLICATION, CONTRAINDICATIONS, AND RISKS
			VI. THE BOTTOM LINE
			VII. CRITICAL THINKING QUESTIONS
			VIII. REFERENCES
	PART V: Mechanical Agents
		Chapter 17: Spinal Traction
			Chapter Outline
			Learning Objectives
			I. FOUNDATION
			II. BIOPHYSICAL CHARACTERISTICS
			III. THERAPEUTIC EFFECTS AND INDICATIONS
			IV. DOSIMETRY
			V. APPLICATION, CONTRAINDICATIONS, AND RISKS
			VI. THE BOTTOM LINE
			VII. CRITICAL THINKING QUESTIONS
			VIII. REFERENCES
		Chapter 18: Limb Compression
			Chapter Outline
			Learning Objectives
			I. FOUNDATION
			II. BIOPHYSICAL CHARACTERISTICS
			III. THERAPEUTIC EFFECTS AND INDICATIONS
			IV. DOSIMETRY
			V. APPLICATION, CONTRAINDICATIONS, AND RISKS
			VI. THE BOTTOM LINE
			VII. CRITICAL THINKING QUESTIONS
			VIII. REFERENCES
		Chapter 19: Continuous Passive Motion
			Chapter Outline
			Learning Objectives
			I. FOUNDATION
			II. BIOPHYSICAL CHARACTERISTICS
			III. THERAPEUTIC EFFECTS AND INDICATIONS
			IV. DOSIMETRY
			V. APPLICATION, CONTRAINDICATIONS, AND RISKS
			VI. THE BOTTOM LINE
			VII. CRITICAL THINKING QUESTIONS
			VIII. REFERENCES
		Chapter 20:Ultrasound
			Chapter Outline
			Learning Objectives
			I. FOUNDATION
			II. BIOPHYSICAL CHARACTERISTICS
			III. THERAPEUTIC EFFECTS AND INDICATIONS
			IV. DOSIMETRY
			V. APPLICATION, CONTRAINDICATIONS, AND RISKS
			VI. THE BOTTOM LINE
			VII. CRITICAL THINKING QUESTIONS
			VIII. REFERENCES
		Chapter 21: Extracorporeal Shockwave Therapy
			Chapter Outline
			Learning Objectives
			I. FOUNDATION
			II. BIOPHYSICAL CHARACTERISTICS
			III. THERAPEUTIC EFFECTS AND INDICATIONS
			IV. DOSIMETRY
			V. APPLICATION, CONTRAINDICATIONS, AND RISKS
			VI. THE BOTTOM LINE
			VII. CRITICAL THINKING QUESTIONS
			VIII. REFERENCES
	INDEX